Apimeds Pharmaceuticals US Inc (APUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 4 | 411 |
| TOTAL | $13 | $422 |
| Non-Current Assets | ||
| TOTAL | $N/A | $N/A |
| Total Assets | $13 | $422 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 668 | 54 |
| Accrued Expenses | 107 | 69 |
| TOTAL | $1,024 | $123 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 347 | 267 |
| TOTAL | $347 | $267 |
| Total Liabilities | $1,371 | $390 |
| Shareholders' Equity | ||
| Common Shares | 79 | 79 |
| Retained earnings | -4,392 | -3,002 |
| TOTAL | $-1,358 | $32 |
| Total Liabilities And Equity | $13 | $422 |